Cyclacel Pharmaceuticals Inc expected to post a loss of 56 cents a share - Earnings Preview

Bio Green Med Solution

08/11/2024 15:45

* Cyclacel Pharmaceuticals Inc  CYCC.OQ   CYCC.O  is
expected
to show a fall in quarterly revenue when it reports  results on
November 11 (estimated) for the period ending September 30 2024
    * The Berkeley Heights New Jersey-based  company is expected
to
report a 68.7% decrease in revenue to $5 thousand from $16
thousand a year ago, according to the mean estimate from 2
analysts, based on LSEG data.
    * ​LSEG's mean analyst estimate for Cyclacel Pharmaceuticals
Inc
is for a loss of 56 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Cyclacel
Pharmaceuticals Inc is $6.00​, above​ its last closing price
of $0.43. ​​​

This summary was machine generated November 8 at 15:45 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)